{
  "title": "M21-1, Part VIII, Subpart i, Chapter 1, Section B - Ratings for Disabilities Associated with Herbicide Exposure",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177423/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-B-Ratings-for-Disabilities-Associated-with-Herbicide-Exposure",
  "content": "<-- Previous Section\nNext Section -->\nOverview\nIn This Section\nThis section contains the following topics:\nTopic\nTopic Name\n1\nConsidering Service Connection (SC) for Disabilities Associated With Exposure to Certain Herbicide Agents\n2\nConsidering SC for Disabilities Associated With Service in the Republic of Vietnam (RVN)\n3\nImpact of Historical Herbicide Exposure Policies\n4\nEffective Date Determinations in Herbicide Exposure Claims\n1\n.\nConsidering SC for Disabilities Associated With Exposure to Certain Herbicide Agents\nIntroduction\nThis topic contains information on considering SC for disabilities associated with exposure to certain herbicide agents, including\npresumptive SC based on herbicide exposure\nrebutting the 38 CFR 3.307(a) presumption by affirmative evidence to the contrary\npresuming exposure to an herbicide agent\ndefinition of service in the RVN\ntime limits for disease manifestation for presumptive purposes under 38 CFR 3.309(e)\nconsidering direct SC when entitlement to presumption does not exist\ndate disabilities became subject to presumptive SC under 38 CFR 3.309(e)\nprocessing claims based on early-onset peripheral neuropathy\nconditions determined to have no positive association with herbicide exposure\nmetastasis of a cancer and presumptive SC under 38 CFR 3.307(a)\n,\nand\ncentralized processing for rating and authorization of herbicide claims\n.\nChange Date\nJuly 19, 2024\nVIII.i.1.B.1.a\n.\nPresumptive SC Based on Herbicide Exposure\nUnder\n38 CFR 3.307\n, when there is\nin-service exposure to an herbicide agent, and\na diagnosis of a condition listed in\n38 CFR 3.309(e)\nwithin a defined time period\na presumption arises that the diagnosis is\nrelated to the exposure, and\nincurred in or aggravated by service.\nThe presumption removes the need to prove a nexus between the current diagnosis and the in-service exposure.  Therefore, when the evidence is sufficient for the presumption to arise, service connection (SC) is established (assuming that generally applicable requirements such as Veteran status based on a qualifying discharge have been met)\nunless\nother evidence rebuts the presumption.\nImportant\n:  Centralized processing is required for the concession of herbicide exposure in some cases as described in\nM21-1, Part VIII, Subpart i, 1.A.1.c\n.\nReferences\n:  For more information on\ncentralized processing of rating and authorization activities in herbicide claims, see\nM21-1, Part VIII, Subpart i, 1.B.1.k\nrebutting the\n38 CFR 3.307(a)\npresumption by affirmative evidence to the contrary, see\nM21-1, Part VIII, Subpart i, 1.B.1.b\n, and\npresuming exposure to an herbicide agent, see\nM21-1, Part VIII, Subpart i, 1.B.1.c\n.\nVIII.i.1.B.1.b\n.\nRebutting the 38 CFR 3.307(a) Presumption by Affirmative Evidence to the Contrary\nThe\n38 CFR 3.307(a)\npresumption of a nexus between a\n38 CFR 3.309(e)\ndisability and established in-service exposure to an herbicide agent can be rebutted by evidence that the disability was not caused by the exposure.\nThe standard in\n38 CFR 3.307(d)\nis\naffirmative evidence to the contrary\n.  The regulation does not specifically define the standard but notes that it means less than conclusive proof and requires sound medical reasoning and consideration of all evidence of record.\nImportant\n:\nAlthough the regulation permits rebuttal, in practice evidence will infrequently support it.  The presumptions were created based on a finding by the Secretary that a positive association exists between the disorders listed in\n38 CFR 3.309(e)\nand herbicide exposure. This finding in turn was based on a study by the National Academy of Science’s (NAS’s) Institute of Medicine.\nA conclusory medical statement that a condition listed in\n38 CFR 3.309(e)\nis not related to demonstrated or presumed herbicide exposure does not meet the sound medical reasoning requirement. There must be competent, credible, and persuasive medical evidence supported by all of the other pertinent evidence of record that the individual’s diagnosed disorder is more likely than not related to a specific non-service-related cause.\nReferences\n:  For more information on\nevaluating evidence, see\nM21-1, Part V, Subpart ii, 1.A\nrequiring further development, see\nM21-1, Part V, Subpart ii, 3.B.1.a\n, and\nthe requirement for supporting medical conclusions with evidence in the claims folder, see\nM21-1, Part V, Subpart ii, 1.A.3.f\n.\nVIII.i.1.B.1.c\n.\nPresuming Exposure to an Herbicide Agent\nCurrently, the Department of Veterans Affairs (VA) recognizes a presumption of exposure to herbicides in specific locations and military service experiences as listed in the table below.\nPresumptive exposure provision applies to ...\nAuthority\nVeterans who served in\nthe Republic of Vietnam (RVN) during the period beginning on January 9, 1962, and ending on May 7, 1975, or\na unit that, as determined by the Department of Defense, operated in or near the Korean demilitarized zone (DMZ) between September 1, 1967, and August 31, 1971, and\nindividuals who performed service in the Air Force or Air Force Reserve under circumstances in which the individual concerned regularly and repeatedly operated, maintained, or served onboard C–123 aircraft known to have been used to spray an herbicide agent during the Vietnam era.\n38 CFR 3.307(a)(6)\nVeterans who served aboard a vessel operating not more than 12 nautical miles seaward of a line commencing on the southwestern demarcation line of the waters of Vietnam and Cambodia and intersecting the coordinates listed in\nPublic Law (\nPL) 116-23\nduring the period beginning January 9, 1962, and ending on May 7, 1975.\n38 U.S.C. 1116A\nlocations during specific time frames as shown in the table below.\nVeterans who performed covered service in/on ...\nDuring the period ...\nThailand at any United States or Royal Thai base, without regard to where on the base the Veteran was located or what military occupational specialty (MOS) the Veteran performed\nJanuary 9, 1962, to June 30, 1976.\nLaos\nDecember 1, 1965, to September 30, 1969.\nCambodia at Mimot or Krek, Kampong Cham Province\nApril 16, 1969, to April 30, 1969.\nGuam or American Samoa, or in the territorial waters thereof\nJanuary 9, 1962, to July 31, 1980.\nJohnston Atoll or on a ship that called at Johnston Atoll\nJanuary 1, 1972, to September 30, 1977.\n38 U.S.C. 1116\nNotes\n:\nFor any contention of in-service exposure to herbicide agents in times or locations other than those specified in one of the above authorities, it is the\nclaimant’s burden\nto\nfactually establish exposure\n.\nThe regulation provides that presumption of exposure to herbicide agents during qualifying service will be rebutted by affirmative evidence that the Veteran was not exposed to any such agent during qualifying service.  However, the probability that specific evidence will exist showing that a person in one of the qualifying locations during a qualifying period had no herbicide exposure is low.\nConcessions of qualifying nautical service are the sole responsibility of the centralized processing teams.\nReference\n:  For more information on centralized processing of herbicide claims, see\nM21-1, Part VIII, Subpart i, 1.A.1.c\n, and\nM21-1, Part VIII, Subpart i, 1.B.1.k\n.\nVIII.i.1.B.1.d\n.\nDefinition:  Service in the RVN\nFor the purposes of the presumption of exposure to herbicide agents under\n38 CFR 3.307(a)(6)(iii)\nand\n38 CFR 3.309(e)\n,\nservice in the RVN\nincludes\non land in the RVN\naboard a vessel operating on the inland waterways of the RVN or eligible offshore waters\naboard vessels on the offshore waters of the RVN, if the conditions of service involved duty or visitation on the ground in the RVN, or\nother locations, if the conditions of service involved duty or visitation on the ground in the RVN.\nThe term service in the RVN does not include service of a Vietnam-era Veteran whose only contact with Vietnam was flying high-altitude missions in Vietnamese airspace.\nImportant\n:  Concession of qualifying RVN nautical service is the sole responsibility of the centralized processing teams and designated legacy appeal personnel.\nReference\ns\n:  For more information on\nservice in the RVN under\n38 CFR 3.313\n, see\nM21-1, Part VIII, Subpart i, 1.B.2\n, and\nVAOPGCPREC 7-1993\nservice in the RVN, see\nVAOPGCPREC 27-1997\n, and\ncentralized processing of herbicide claims, see\nM21-1, Part VIII, Subpart i, 1.A.1.c\n, and\nM21-1, Part VIII, Subpart i, 1.B.1.k\n.\nVIII.i.1.B.1.e\n.\nTime Limits for Disease Manifestation for Presumptive Purposes Under 38 CFR 3.309(e)\nIn order to establish presumptive SC, the following diseases listed in\n38 CFR 3.309(e)\nmust become manifest to a degree of 10 percent or more within one year of the\nlast date of exposure\nto herbicides\nchloracne or other acne-form disease consistent with chloracne\nporphyria cutanea tarda (PCT), and\nearly-onset peripheral neuropathy.\nNotes\n:\nThere is no time limit for the other listed presumptive diseases in\n38 CFR 3.309(e)\n.\nPreviously, respiratory cancers (cancers of the lung, bronchus, larynx, and trachea) had to become manifest within 30 years of last exposure.\nPL 107-103\neliminated this requirement effective January 1, 2002.\nFor the purposes of establishing onset within the required manifestation period, the\nlast date of herbicide exposure\nis the last date on which the Veteran served in a location associated with a presumption of herbicide exposure as listed in\n38 U.S.C. 1116\n.\nReference\n:  For more information on\ntime limits for manifestation of diseases subject to presumptive SC, see\n38 CFR 3.307(a)(6)(ii)\n.\nVIII.i.1.B.1.f\n.\nConsidering Direct SC When Entitlement to Presumption Does Not Exist\nIf entitlement to presumptive SC based on herbicide exposure does not exist, consider entitlement to SC on a direct, facts-found basis under the toxic exposure risk activity (TERA) procedures.\nNotes\n:\nUnder\n38 CFR 3.303(d)\n, the presumptive provisions of the statute and VA regulations implementing them are intended as liberalizations that allow for another basis of SC.  Therefore, these provisions do\nnot\npreclude direct SC, where appropriate.\nTERA procedures went into effect on August 10, 2022, under\nPL 117-168\n, Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics (PACT) Act of 2022.\nReferences\n:  For more information on\nTERA procedures, see the\nPACT Act Implementation Standard Operating Procedure (SOP)\n, and\nconditions determined to have no positive association with herbicide exposure, see\nM21-1, Part VIII, Subpart i, 1.B.1.i\n.\nVIII.i.1.B.1.g\n.\nDate Disabilities Became Subject to Presumptive SC Under 38 CFR 3.309(e)\nThe table below shows the dates on which the diseases listed in\n38 CFR 3.309(e)\nbecame subject to presumptive SC.\nDisability\nEffective Date\nChloracne or other acne-form disease consistent with chloracne, and\nsoft-tissue sarcoma,\nother than\nosteosarcoma\nchondrosarcoma\nKaposi’s sarcoma, or\nmesothelioma\nFebruary 6, 1991\nNote\n:  Originally, September 25, 1985, under 38 CFR 3.311a.\nNon-Hodgkin’s lymphoma (NHL)\nFebruary 6, 1991\nNote\n:  Originally, August 5, 1964, under 38 CFR 3.313.\nPCT, and\nHodgkin’s disease\nFebruary 3, 1994\nRespiratory cancers of the\nlung\nbronchus\nlarynx, or\ntrachea, and\nmultiple myeloma\nJune 9, 1994\nProstate cancer, and\nacute and subacute peripheral neuropathy\nNovember 7, 1996\nType 2 diabetes mellitus\nMay 8, 2001\nChronic lymphocytic leukemia (CLL)\nOctober 16, 2003\nAL amyloidosis\nMay 7, 2009\nIschemic heart disease (IHD)\nchronic B-cell leukemia, and\nParkinson’s disease\nAugust 31, 2010\nEarly-onset peripheral neuropathy\nSeptember 6, 2013\nParkinsonism\nbladder cancer, and\nhypothyroidism.\nReference\n:  For more information on presumptive SC for these disabilities, see\nPL 116-283\n,\nWilliam M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021\n, and\nVeterans Benefits Administration (VBA) Letter 20-21-07, Processing Guidance for Claims and Appeals for New Agent Orange Presumptive Conditions\n.\nJanuary 1, 2021\nmonoclonal gammopathy of undetermined significance, and\nhypertension\nReference\n:  For more information on processing claims for these disabilities, see the\nPACT Act Implementation SOP\n.\nAugust 10, 2022\nImportant\n:  The table above includes reference to acute and subacute peripheral neuropathy becoming subject to presumptive SC on November 7, 1996, for historical purposes. The covered disease was revised to early-onset peripheral neuropathy by change effective September 6, 2013.  For claims on or after September 6, 2013, entitlement to presumptive SC based on peripheral neuropathy only exists when the Veteran meets qualifying service requirements specified at\nM21-1, Part VIII, Subpart i, 1.B.1.c\nand medical evidence establishes a confirmed diagnosis of early-onset peripheral neuropathy.\nNote\n:  Unless an earlier effective date is determined pursuant to the\nNehmer\nstipulation under\n38 CFR 3.816\n, the provisions pertaining to retroactive payment under\n38 CFR 3.114(a)\napply.\nReference\n:  For more information on the\nNehmer\nstipulation, see\n38 CFR 3.816\nM21-1, Part VIII, Subpart i, 2.B\n, and\nthe\nNehmer Training Guide\n.\nVIII.i.1.B.1.h\n.\nProcessing Claims Based on Early-Onset Peripheral Neuropathy\nA change to\n38 CFR 3.307(a)(6)\nand\n38 CFR 3.309(e)\n(\n78 FR 54763\n) effective September 6, 2013, removed requirements that neuropathy must resolve within two years.\nDo not deny presumptive SC for early-onset peripheral neuropathy solely because the condition persisted for more than two years after initial diagnosis.\nImportant\n:\nThe regulatory amendment does not change that peripheral neuropathy must manifest to a compensable degree of 10 percent or more within one year of the date of last herbicide exposure during active military, naval, or air service.\nClaims of SC for later-occurring onset of peripheral neuropathy can only be evaluated under other bases (for example, direct or secondary).  NAS has determined that evidence does not support an association between herbicide exposure and delayed-onset peripheral neuropathy, which NAS defined as having its onset more than one year after exposure.\nVIII.i.1.B.1.i\n.\nConditions Determined to Have No Positive Association With Herbicide Exposure\nWhen processing claims for disabilities not recognized as presumptive to herbicide exposure, follow the direct SC TERA procedures.  Review the claimed disability and determine if it falls under the exception for conditions determined to have no positive association with herbicide exposure listed below.\nBased on cumulative scientific data reported by NAS since 1993, the Secretary has determined that a positive association does not exist between herbicide exposure and the following conditions and that a presumption of SC is not warranted for any of the conditions:\nCancers\nbone and connective tissue\nbrain and nervous system (including eye)\ndigestive (esophageal, stomach, and colorectal (including small intestine and anus))\nendocrine (including thyroid and thymus)\nhepatobiliary (liver, gallbladder, and bile ducts) and pancreatic\nleukemia (\nexcluding\nall chronic B-cell leukemias including CLL and hairy cell)\nnasal cavity (including ears and sinuses)\noral cavity (including lips and tongue)\npharynx (including tonsils)\npleura, mediastinum, and other unspecified sites within the respiratory system and intrathoracic organs\nskin (including melanoma and nonmelanoma (basal cell and squamous cell), and\nreproductive (including the cervix, uterus, ovary, testes, breast, and penis, but\nexcluding\nprostate)\n.\nOther\nasthma\nchronic obstructive pulmonary disease (COPD)\ncirculatory disorders (\nbut excluding\nhypertension, IHD, and stroke)\nendometriosis\neye diseases\nFarmer’s lung\ngastrointestinal, metabolic, and digestive disorders\nhearing loss\nimmune system disorders (immune suppression, allergy, and autoimmunity)\nneurobehavioral (cognitive and neuropsychiatric) disorders\nneurodegenerative diseases (including amyotrophic lateral sclerosis (ALS), but\nexcluding\nParkinson's disease and Parkinsonism)\nosteoporosis, and\nchronic peripheral nervous system disorders (\nbut\nexcluding\nearly-onset peripheral neuropathy)\n.\nNote\n:  No positive association means that the evidence for an association does not equal or outweigh the evidence against association.\nReferences\n:  For more information on\nprocessing TERA claims, see the\nPACT Act Implementation SOP\n, and\nTERA exceptions, see\nVBA Letter, 20-24-06, Updated Guidance on Processing Claims involving PACT Act\n.\nVIII.i.1.B.1.j\n.\nMetastasis of a Cancer and Presumptive SC Under 38 CFR 3.307(a)\nDo not establish presumptive SC on the basis of herbicide exposure under\n38 U.S.C. 1116\nand\n38 CFR 3.307(a)\nfor a cancer listed in\n38 CFR 3.309(e)\nwhen medical evidence factually shows that the cancer developed as the result of metastasis of a cancer located at a primary site that is not recognized by the VA as associated with herbicide exposure.\nNote\n:  Such evidence constitutes affirmative evidence to rebut the presumption of SC based on herbicide exposure.\nVIII.i.1.B.1.k\n.\nCentralized Processing for Rating and Authorization of Herbicide Claims\nCentralized processing of the rating and authorization activities is required for certain herbicide claims.  These include cases with\nexplicit or implicit claims of RVN-based nautical service, and\nno in-country service at a presumptive herbicide location, or\na previously denied claim based on no qualifying service, or\nservice in the RVN,\nand\npotential\nNehmer\napplicability under\n38 CFR 3.816\n.\nReferences\n:  For more information on\nexplicit or implicit claims of RVN-based nautical service, see the\nPACT Act Implementation SOP\ncontent titled,\nEvidence of Nautical Service\n, and\nclaims requiring centralized processing for research of herbicide exposure, see\nM21-1, Part VIII, Subpart i, 1.A.1.c\n.\n2.\nConsidering SC for Disabilities Associated With Service in the RVN\nIntroduction\nThis topic contains information on SC for disabilities associated with service in the RVN, including\nSC for NHL under 38 CFR 3.313 based on service in the RVN during the Vietnam era\n, and\nsubcategories of NHL qualifying for presumptive SC\n.\nChange Date\nDecember 4, 2023\nVIII.i.1.B.2.a\n.\nSC for NHL Under 38 CFR 3.313 Based on Service in the RVN During the Vietnam Era\nVA regulations at\n38 CFR 3.313\nprovide for a presumption of SC for NHL based on service in the RVN during the Vietnam era.\nImportant\n:\nExposure to herbicides is not a prerequisite for entitlement under\n38 CFR 3.313\n.  The claimant needs only to show service in the RVN, which includes the waters offshore.\nIf a claim for NHL under\n38 CFR 3.313\nrequires research of RVN nautical service, it must be referred for centralized processing as noted in\nM21-1, VIII, Subpart i, 1.A.1.c\n.\nReference\n:  For more information on presumptive SC for NHL based on presumptive herbicide exposure, see\n38 CFR 3.309(e)\n, and\nM21-1, Part VIII, Subpart i, 1.B.1.g\n.\nVIII.i.1.B.2.b\n.\nSubcategories of NHL Qualifying for Presumptive SC\nWhen\n38 CFR 3.313\nwas promulgated, the U.S. Center for Disease Control identified a number of subcategories that are manifestations of NHL.\nExtend the presumption of SC to a Veteran who claims SC for NHL if\nthe Veteran had service in the RVN during the Vietnam era, including naval service in the offshore waters of the RVN, and\nthe medical evidence shows a diagnosis of any of the subcategories of low, intermediate, or high-grade lymphoma listed in the table below.\nLow Grade Lymphoma\nIntermediate Grade Lymphoma\nHigh Grade Lymphoma\nSmall lymphocytic with plasmacytoid features\nDiffuse, small and large\nDiffuse, small and large\nSmall lymphocytic lymphoma and B-cell CLL\nNote\n:  Small lymphocytic lymphoma and B-cell CLL are considered slightly different forms of the same disease.\nDiffuse, small cleaved\nLymphoblastic\nIntermediate cell\nDiffuse, large cleaved\nImmunoblastic\nFollicular, mixed small and large\nDiffuse, large non-cleaved\nBurkitt’s\nMantle zone\nDiffuse, large\n---\nFollicular, small cleaved\nFollicular, large\n---\nWaldenstrom’s macroglobulinemia\n---\n---\nMycosis fungoides\nReference\n:  For more information on considering claims for SC for mycosis fungoides, see\nM21-1, Part V, Subpart iii, 10.4.c\n.\n---\n---\n3.\nImpact of Historical Herbicide Exposure Policies\nIntroduction\nThis topic contains information on the impact of historical herbicide exposure policies, including\noverview of historical policies regarding herbicide exposure and nautical service\n, and\nbenefits previously awarded under historical policies\n.\nChange Date\nDecember 4, 2023\nVIII.i.1.B.3.a\n.\nOverview of Historical Policies Regarding Herbicide Exposure and Nautical Service\nThe table below represents time periods during which VA had specific policies in place regarding concession of herbicide exposure based on nautical service.\nGuidance Time Period\nExposure Policy\npre-\nHaas\n(1991-2002)\nExposure conceded based on receipt of the Vietnam Service Medal (VSM).\n2002\nRemoved concession for VSM from M21-1 guidance.\nFast Letter (FL) 06-26\n(December 11, 2006)\nAll blue water Navy claims stayed based on the\nHaas\ndecision.\nHaas\nstay lifted,\nFL 09-07\n(February 6, 2009)\nExposure conceded based on review of military records for\ninland waterways service of the RVN, or\nservice on a ship that docked, if the Veteran provided a lay statement that he went ashore.\nTraining Letter 10-06\n(September 9, 2010)\nConcession based on categories of ships on the\nNavy and Coast Guard Ships Associated with Service in Vietnam and Exposure to Herbicide Agents\n, a.k.a., the Ships List.\nVeterans Service Center Manager (VSCM) Call (January 2011)\nShips List updated with Category IV,\nShips operating on Vietnam’s close coastal waters for extended periods with evidence that crew members went ashore\n(lay statement of going ashore required).\nVSCM Call (May 2011)\nShips List updated with Category V,\nShips operating on Vietnam’s close coastal waters for extended periods with evidence that smaller craft from the ship regularly delivered supplies or troops ashore\n(lay statement of going ashore required).\nPL 116-23\n(January 1, 2020)\nDefinition of service in the RVN expanded to include eligible offshore waters.  Use of the Ships List discontinued and replaced with VBA’s internal claims processing tools used to determine a ship’s location(s).\nPACT Act (August 10, 2022)\nExpanded presumptive herbicide exposure to additional nautical locations by amending\n38 U.S.C. 1116\n.\nVIII.i.1.B.3.b\n.\nBenefits Previously Awarded Under Historical Policies\nWhen reviewing initial or supplemental claims decided under historical nautical service herbicide exposure policies,\ndo not\npropose to sever SC for the disabilities previously awarded when the presumption of herbicide exposure was conceded under former policies, or\nconcede herbicide exposure for any newly claimed disabilities unless evidence is presented that otherwise establishes the Veteran’s exposure based on current evidentiary requirements.\nImportant\n:\nBefore deciding any initial or supplemental claim based on herbicide exposure, always apply the most current standards and definitions of qualifying service and review all available records.\nThe protection noted above applies to SC for the disability awarded based on a historical policy.  Once a disability has been service-connected (SC), even erroneously, and protection has attached, then the Veteran is entitled to increased evaluations for the disability, to SC for secondary conditions, and to awards of individual unemployability based solely or partly on those SC conditions.\nReferences\n:  For more information on\nprotection of SC, see\n38 CFR 3.957\n, and\n38 U.S.C. 1159\nnew interpretations of the law and clear and unmistakable error, see\nBerger v. Brown\n, 10 Vet. App. 166 (1997), and\nJordan v. Nicholson\n, 401 F.3d 1296 (Fed. Cir. 2005), and\nblue water Navy Veterans and herbicide exposure, see\nHaas v. Peake\n, 535 F.3d 1168 (Fed. Cir. 2008).\n4.\nEffective Date Determinations in Herbicide Exposure Claims\nIntroduction\nThis topic contains information on effective date determinations in herbicide exposure claims, including\nmaximizing benefits with effective date determinations in herbicide claims\neffective dates based on herbicide exposure and CFR 3.156(c)\ndetermining applicability of 38 CFR 3.156(c) or 38 CFR 3.114 for exposure to herbicides in Korea\n, and\nexamples of determining effective date in a claim based on herbicide exposure in Korea\n.\nChange Date\nJuly 29, 2021\nVIII.i.1.B.4.a\n.\nMaximizing Benefits With Effective Date Determinations in Herbicide Claims\nWhen awarding SC for a disability under\n38 CFR 3.309(e)\n, different provisions allow for assignment of an effective date.  In such cases, consider each effective date rule and assign the most advantageous effective date that applies for the facts of the case.\nUse the table below to determine which effective date rule may apply to an award of SC for a\n38 CFR 3.309(e)\ndisability.\nIf ...\nThen consider entitlement to an effective date under ...\nReference\nthe claimant filed the claim prior to the date VA added the presumptive disability to\n38 CFR 3.309(e)\n38 CFR 3.816\n.\nM21-1, Part VIII, Subpart i, 2.B\nthe claimant met all eligibility criteria for a benefit on the effective date of a liberalizing law change as detailed in\nM21-1, Part V, Subpart ii, 4.A.6.h\n38 CFR 3.114(a)\n.\nM21-1, Part V, Subpart ii, 4.A.6\nthe claimant is entitled to retroactive payment of benefits based on\nPL 116-23\n38 U.S.C. 1116A\n.\nNautical Herbicide Exposure Centralized Processing SOP\nthe claim was previously denied because available service records did not establish the Veteran had qualifying service, and\nnewly received service records establish service in a qualifying location\n38 CFR 3.156(c)\n.\nM21-1, Part VIII, Subpart i, 1.B.4.b\n-\nd\nnone of the above special provisions apply\n38 CFR 3.400\n, or\n38 CFR 3.2500\n.\nM21-1, Part V, Subpart ii, 4.A\n.\nReference\n:  For more information on establishing an effective date under the PACT Act, see the\nPACT Act Implementation SOP\n.\nVIII.i.1.B.4.b\n.\nEffective Dates Based on Herbicide Exposure and CFR 3.156(c)\nIf a claim based on exposure to herbicides was previously denied because available service records did not establish the Veteran had qualifying service, decision makers must review any newly available service records to determine if new evidence of qualifying service exists.\nReconsider the claim under\n38 CFR 3.156(c)\nif newly received service records result in\npresumption of herbicide exposure based on location of service, or\nconcession of herbicide exposure on a factual basis.\nAs stated in\n38 CFR 3.156(c)(3)\n, if the evidence now justifies the establishment of SC, the effective date will be the later of\nthe date entitlement arose, or\nthe date VA received the previously decided claim.\nNotes\n:\nThe date entitlement arose may be either the\ndate the claimed disease was diagnosed (or symptoms became manifest according to medical evidence), or\nthe date the claimed presumptive disease was finalized as part of the presumptive list of herbicide exposure-related diseases in\n38 CFR 3.309(e)\n.\nDecision makers must also consider the effective date provisions of\n38 CFR 3.114\nand the\nNehmer\nstipulation, when applicable.\nReferences\n:  For more information on\ndeveloping claims based on herbicide exposure, see\nM21-1, Part VIII, Subpart i, 1.A\n, and\nthe\nNehmer\nstipulation, see\n38 CFR 3.816\nM21-1, Part VIII, Subpart i, 2.B\n, and\nthe\nNehmer Training Guide\n.\nVIII.i.1.B.4.c\n.\nDetermining Applicability of 38 CFR 3.156(c) or 38 CFR 3.114 for Exposure to Herbicides in Korea\nEffective dates based on a grant of SC for a disability associated with exposure to herbicides in the Korean DMZ can be affected by liberalizing changes and/or receipt of additional service department records.\nTwo\nliberalizing changes to the provisions of\n38 CFR 3.307(a)(6)(iv)\n(as discussed more thoroughly in\nM21-1, Part VIII, Subpart i, 1.A.3.b\n) have been made to revise the applicable dates for the concession of exposure to herbicides for Veterans who served in specific designated units operating in or near the Korean DMZ.\nWhen a claim for SC associated with exposure to herbicides in Korea was previously denied, but entitlement to the benefit is now established based on\nexpanded regulatory authority not in effect at the time of the prior decision, apply\n38 CFR 3.114(a)\nif all other criteria for applicability are satisfied, or\nnew service records received from the service department that establish exposure based on the regulatory provision in place at the time of the previously adjudicated claim, apply\n38 CFR 3.156(c)\nif all other criteria for applicability are satisfied.\nReferences\n:  For more information on\nconsidering additional service records, see\nM21-1, Part X, Subpart ii, 2.B\nassigning effective dates based on liberalizing regulatory changes, see\n38 CFR 3.114(a)\n, and\nM21-1, Part V, Subpart ii, 4.A.6\n, and\nrequirements for presumptive SC based on herbicide exposure in the Korean DMZ, see\nM21-1, Part VIII, Subpart i, 1.A.3.a\n.\nVIII.i.1.B.4.d\n.\nExamples of Determining Effective Date in a Claim Based on Herbicide Exposure in Korea\nFacts\n:  The Veteran previously claimed and was denied SC for prostate cancer due to herbicide exposure in Korea.  The Veteran was notified of the denial on July 18, 2010.  The service records at that time showed that the Veteran served in a designated unit in the Korean DMZ, but the dates of service were in October to November 1970.  The Veteran has submitted a supplemental claim for SC for prostate cancer due to herbicide exposure in Korea.\nAnalysis\n:  The liberalizing law change of February 24, 2011, expanded the applicable dates for presumption of exposure for Veterans who served in a designated unit in the Korean DMZ to include dates of service through August 31, 1971.  Since the Veteran’s service in 1970 falls within the designated time period, SC is now warranted.  Given that SC is warranted based on the liberalizing law change expanding the applicable time period associated with Korean service, apply\n38 CFR 3.114\nto assign an effective date one year prior to the date of receipt of the supplemental claim if all other criteria for applicability of this regulation are otherwise satisfied.\nFacts\n:  The Veteran previously claimed and was denied SC for lung cancer due to herbicide exposure in Korea.  The claim was received on March 12, 2015, and the Veteran was notified of the denial on August 22, 2015.  The Veteran claimed to have been assigned on temporary duty orders to a designated unit in the DMZ during the spring of 1969.  Development attempts were made for records of the Veteran’s assignments, and no evidence was received to verify the claimed service.  In 2019, the Veteran submitted a supplemental claim with new and relevant evidence.  Development for that claim revealed recently declassified records confirming that the Veteran was sent on temporary duty orders to a designated unit in the Korean DMZ in 1969.\nAnalysis\n:  Receipt of additional service records confirming service in a designated unit in the Korean DMZ in 1969 is sufficient to allow presumption of herbicide exposure under\n38 CFR 3.307(a)(6)(iv)\n.  Assuming all other criteria are met, the prior denial of SC must be reconsidered and revised under\n38 CFR 3.156(c)\n.  SC for lung cancer is warranted effective March 12, 2015.\n<-- Previous Section\nNext Section -->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000177422\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 1, Section A - Developing Claims for Service Connection (SC) Based on Herbicide Exposure\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177422/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-A-Developing-Claims-for-Service-Connection-SC-Based-on-Herbicide-Exposure\">&lt;-- Previous Section</a>  <a articleid=\"554400000177424\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 2, Section A - Developing Claims Under the Nehmer Stipulation\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177424/M21-1-Part-VIII-Subpart-i-Chapter-2-Section-A-Developing-Claims-Under-the-Nehmer-Stipulation\">Next Section --&gt;</a></span></span></p><p class=\"ng-scope\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">Overview</span></span></a></p><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In This Section</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This section contains the following topics: </span></span></div><div></div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"height: 0px; width: 495px; border-spacing: 0px; border-collapse: revert;\" width=\"495\"><tbody><tr><td style=\"width: 87px; padding: 0px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Topic</strong></span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Topic Name</strong></span></span></div></td></tr><tr><td style=\"width: 87px; padding: 0px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">1</span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1\" target=\"_self\">Considering Service Connection (SC) for Disabilities Associated With Exposure to Certain Herbicide Agents</a></span></span></div></td></tr><tr><td style=\"width: 87px; padding: 0px;\"><div align=\"center\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">2</span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#2\" target=\"_self\">Considering SC for Disabilities Associated With Service in the Republic of Vietnam (RVN)</a></span></span></div></td></tr><tr><td style=\"width: 87px; padding: 0px;\"><div align=\"center\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">3</span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#3\" target=\"_self\">Impact of Historical Herbicide Exposure Policies</a></span></span></div></td></tr><tr><td style=\"width: 87px; padding: 0px;\"><div align=\"center\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">4</span></span></div></td><td style=\"width: 333px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4\" target=\"_self\">Effective Date Determinations in Herbicide Exposure Claims</a></span></span></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/><p></p><p></p></div><h2 class=\"ng-scope\"> <span style=\"font-size: 16px\"><span style=\"font-family: arial, helvetica, sans-serif\">1<a id=\"1\" name=\"1\">.</a>  Considering SC for Disabilities Associated With Exposure to Certain Herbicide Agents</span></span></h2><p class=\"ng-scope\"></p><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This topic contains information on considering SC for disabilities associated with exposure to certain herbicide agents, including</span></span></div><ul><li><div><a href=\"#1a\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">presumptive SC based on herbicide exposure</span></span></a></div></li><li><div><a href=\"#1b\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">rebutting the 38 CFR 3.307(a) presumption by affirmative evidence to the contrary</span></span></a></div></li><li><div><a href=\"#1c\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">presuming exposure to an herbicide agent</span></span></a></div></li><li><div><a href=\"#1d\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">definition of service in the RVN</span></span></a></div></li><li><div><a href=\"#1e\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">time limits for disease manifestation for presumptive purposes under 38 CFR 3.309(e)</span></span></a></div></li><li><div><a href=\"#1f\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">considering direct SC when entitlement to presumption does not exist</span></span></a></div></li><li><div><a href=\"#1g\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">date disabilities became subject to presumptive SC under 38 CFR 3.309(e)</span></span></a></div></li><li><div><a href=\"#1h\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">processing claims based on early-onset peripheral neuropathy</span></span></a></div></li><li><div><a href=\"#1i\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">conditions determined to have no positive association with herbicide exposure</span></span></a></div></li><li><div><a href=\"#1j\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">metastasis of a cancer and presumptive SC under 38 CFR 3.307(a)</span></span></a>, <span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1k\" target=\"_self\">centralized processing for rating and authorization of herbicide claims</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><strong><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></strong></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">July 19, 2024</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.1.a<a id=\"1a\" name=\"1a\">.</a>  Presumptive SC Based on Herbicide Exposure</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1307&amp;rgn=div8\" target=\"_blank\">38 CFR 3.307</a>, when there is</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">in-service exposure to an herbicide agent, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">a diagnosis of a condition listed in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a> within a defined time period</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">a presumption arises that the diagnosis is</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">related to the exposure, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">incurred in or aggravated by service. </span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The presumption removes the need to prove a nexus between the current diagnosis and the in-service exposure.  Therefore, when the evidence is sufficient for the presumption to arise, service connection (SC) is established (assuming that generally applicable requirements such as Veteran status based on a qualifying discharge have been met) <em>unless</em> other evidence rebuts the presumption.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Important</em></strong>:  Centralized processing is required for the concession of herbicide exposure in some cases as described in <a articleid=\"554400000177422\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 1, Section A - Developing Claims for Service Connection (SC) Based on Herbicide Exposure\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177422/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-A-Developing-Claims-for-Service-Connection-SC-Based-on-Herbicide-Exposure\">M21-1, Part VIII, Subpart i, 1.A.1.c</a>.  </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">centralized processing of rating and authorization activities in herbicide claims, see <a href=\"#1k\" target=\"_self\">M21-1, Part VIII, Subpart i, 1.B.1.k</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">rebutting the <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1307&amp;rgn=div8\" target=\"_blank\">38 CFR 3.307(a)</a> presumption by affirmative evidence to the contrary, see <a href=\"#1b\" target=\"_self\">M21-1, Part VIII, Subpart i, 1.B.1.b</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">presuming exposure to an herbicide agent, see <a href=\"#1c\" target=\"_self\">M21-1, Part VIII, Subpart i, 1.B.1.c</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.1.b<a id=\"1b\" name=\"1b\">.</a>  Rebutting the 38 CFR 3.307(a) Presumption by Affirmative Evidence to the Contrary</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1307&amp;rgn=div8\" target=\"_blank\">38 CFR 3.307(a)</a> presumption of a nexus between a <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a> disability and established in-service exposure to an herbicide agent can be rebutted by evidence that the disability was not caused by the exposure.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The standard in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1307&amp;rgn=div8\" target=\"_blank\">38 CFR 3.307(d)</a> is <em>affirmative evidence to the contrary</em>.  The regulation does not specifically define the standard but notes that it means less than conclusive proof and requires sound medical reasoning and consideration of all evidence of record.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Important</em></strong>:  </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Although the regulation permits rebuttal, in practice evidence will infrequently support it.  The presumptions were created based on a finding by the Secretary that a positive association exists between the disorders listed in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a> and herbicide exposure. This finding in turn was based on a study by the National Academy of Science’s (NAS’s) Institute of Medicine.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">A conclusory medical statement that a condition listed in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a> is not related to demonstrated or presumed herbicide exposure does not meet the sound medical reasoning requirement. There must be competent, credible, and persuasive medical evidence supported by all of the other pertinent evidence of record that the individual’s diagnosed disorder is more likely than not related to a specific non-service-related cause.</span></span></li></ul><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></p><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">evaluating evidence, see <a articleid=\"554400000014383\" articlename=\"M21-1, Part V, Subpart ii, Chapter 1, Section A - Principles of Reviewing and Weighing Evidence\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014383/M21-1-Part-V-Subpart-ii-Chapter-1-Section-A-Principles-of-Reviewing-and-Weighing-Evidence\">M21-1, Part V, Subpart ii, 1.A</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">requiring further development, see <a articleid=\"554400000180487\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section B - Making Partial Rating Decisions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180487/M21-1-Part-V-Subpart-ii-Chapter-3-Section-B-Making-Partial-Rating-Decisions\">M21-1, Part V, Subpart ii, 3.B.1.a</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the requirement for supporting medical conclusions with evidence in the claims folder, see <a articleid=\"554400000014383\" articlename=\"M21-1, Part V, Subpart ii, Chapter 1, Section A - Principles of Reviewing and Weighing Evidence\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014383/M21-1-Part-V-Subpart-ii-Chapter-1-Section-A-Principles-of-Reviewing-and-Weighing-Evidence\">M21-1, Part V, Subpart ii, 1.A.3.f</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.1.c<a id=\"1c\" name=\"1c\">.</a>  Presuming Exposure to an Herbicide Agent</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Currently, the Department of Veterans Affairs (VA) recognizes a presumption of exposure to herbicides in specific locations and military service experiences as listed in the table below. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\" summary=\"This is a two column table.  Column 1 contains the individuals that presumptive exposure provision applies to and column 2 contains the authority.  The 3rd row contains an additional table.\" width=\"504\"><thead><tr><th scope=\"col\" style=\"padding: 0px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b>Presumptive exposure provision applies to ...</b></span></span></div></th><th scope=\"col\" style=\"padding: 0px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b>Authority</b></span></span></div></th></tr></thead><tbody><tr><td style=\"padding: 0px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Veterans who served in</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">the Republic of Vietnam (RVN) during the period beginning on January 9, 1962, and ending on May 7, 1975, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">a unit that, as determined by the Department of Defense, operated in or near the Korean demilitarized zone (DMZ) between September 1, 1967, and August 31, 1971, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">individuals who performed service in the Air Force or Air Force Reserve under circumstances in which the individual concerned regularly and repeatedly operated, maintained, or served onboard C–123 aircraft known to have been used to spray an herbicide agent during the Vietnam era.</span></span></div></li></ul></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1307&amp;rgn=div8\" target=\"_blank\">38 CFR 3.307(a)(6)</a></span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Veterans who served aboard a vessel operating not more than 12 nautical miles seaward of a line commencing on the southwestern demarcation line of the waters of Vietnam and Cambodia and intersecting the coordinates listed in <i>Public Law (</i><i>PL) 116-23</i> during the period beginning January 9, 1962, and ending on May 7, 1975.</span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://www.law.cornell.edu/uscode/text/38/1116A\" target=\"_blank\">38 U.S.C. 1116A</a></span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">locations during specific time frames as shown in the table below.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\" summary=\"This is a two column table.  Column 1 contains the individuals that performed covered service and column 2 contains the period served.\"><tbody><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b>Veterans who performed covered service in/on ...</b></span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b>During the period ...</b></span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Thailand at any United States or Royal Thai base, without regard to where on the base the Veteran was located or what military occupational specialty (MOS) the Veteran performed</span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">January 9, 1962, to June 30, 1976.</span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Laos</span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">December 1, 1965, to September 30, 1969.</span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Cambodia at Mimot or Krek, Kampong Cham Province</span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">April 16, 1969, to April 30, 1969.</span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Guam or American Samoa, or in the territorial waters thereof</span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">January 9, 1962, to July 31, 1980.</span></span></div></td></tr><tr><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Johnston Atoll or on a ship that called at Johnston Atoll</span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">January 1, 1972, to September 30, 1977.</span></span></div></td></tr></tbody></table><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">  </span></span></div></td><td style=\"padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://www.law.cornell.edu/uscode/text/38/1116\" target=\"_blank\">38 U.S.C. 1116</a></span></span></div></td></tr></tbody></table></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Notes</em></strong>: </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">For any contention of in-service exposure to herbicide agents in times or locations other than those specified in one of the above authorities, it is the <em>claimant’s burden</em> to <em>factually establish exposure</em>.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The regulation provides that presumption of exposure to herbicide agents during qualifying service will be rebutted by affirmative evidence that the Veteran was not exposed to any such agent during qualifying service.  However, the probability that specific evidence will exist showing that a person in one of the qualifying locations during a qualifying period had no herbicide exposure is low. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Concessions of qualifying nautical service are the sole responsibility of the centralized processing teams.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on centralized processing of herbicide claims, see </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000177422\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 1, Section A - Developing Claims for Service Connection (SC) Based on Herbicide Exposure\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177422/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-A-Developing-Claims-for-Service-Connection-SC-Based-on-Herbicide-Exposure\">M21-1, Part VIII, Subpart i, 1.A.1.c</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1k\" target=\"_self\">M21-1, Part VIII, Subpart i, 1.B.1.k</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.1.d<a id=\"1d\" name=\"1d\">.</a>  Definition:  Service in the RVN</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">For the purposes of the presumption of exposure to herbicide agents under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1307&amp;rgn=div8\" target=\"_blank\">38 CFR 3.307(a)(6)(iii)</a> and <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=f97bef91876080300247e2290a6ca2b2&amp;mc=true&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a>, <em><strong>service in the RVN</strong></em> includes</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">on land in the RVN</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">aboard a vessel operating on the inland waterways of the RVN or eligible offshore waters</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">aboard vessels on the offshore waters of the RVN, if the conditions of service involved duty or visitation on the ground in the RVN, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">other locations, if the conditions of service involved duty or visitation on the ground in the RVN.</span></span></div></li></ul><div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">The term service in the RVN does not include service of a Vietnam-era Veteran whose only contact with Vietnam was flying high-altitude missions in Vietnamese airspace. </span></span></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Important</em></strong>:  Concession of qualifying RVN nautical service is the sole responsibility of the centralized processing teams and designated legacy appeal personnel.  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Reference</em>s</strong>:  For more information on</span></span></div><ul><li class=\"BulletText1\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">service in the RVN under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1313&amp;rgn=div8\" target=\"_blank\">38 CFR 3.313</a>, see </span></span></div><ul><li class=\"BulletText1\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#2\" target=\"_self\">M21-1, Part VIII, Subpart i, 1.B.2</a>, and</span></span></div></li><li class=\"BulletText1\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000043468\" articlename=\"VAOPGCPREC 07-93, Aug 12, 1993, Service in Vietnam Under 38 CFR 3.313\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043468/VAOPGCPREC-07-93-Aug-12-1993-Service-in-Vietnam-Under-38-CFR-3313\">VAOPGCPREC 7-1993</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">service in the RVN, see </span></span><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000043711\" articlename=\"VAOPGCPREC 27-97, Jul 23, 1997, Service in the Republic of Vietnam for Purposes of Definition of Vietnam Era - 38 U.S.C. 101(29)(A)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043711/VAOPGCPREC-27-97-Jul-23-1997-Service-in-the-Republic-of-Vietnam-for-Purposes-of-Definition-of-Vietnam-Era-38-USC-10129A\">VAOPGCPREC 27-1997</a>, and </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">centralized processing of herbicide claims, see </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000177422\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 1, Section A - Developing Claims for Service Connection (SC) Based on Herbicide Exposure\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177422/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-A-Developing-Claims-for-Service-Connection-SC-Based-on-Herbicide-Exposure\">M21-1, Part VIII, Subpart i, 1.A.1.c</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1k\" target=\"_self\">M21-1, Part VIII, Subpart i, 1.B.1.k</a>.</span></span></div></li></ul></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.1.e<a id=\"1e\" name=\"1e\">.</a>  Time Limits for Disease Manifestation for Presumptive Purposes Under 38 CFR 3.309(e)</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">In order to establish presumptive SC, the following diseases listed in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a> must become manifest to a degree of 10 percent or more within one year of the <em>last date of exposure</em> to herbicides </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">chloracne or other acne-form disease consistent with chloracne</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">porphyria cutanea tarda (PCT), and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">early-onset peripheral neuropathy.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Notes</em></strong>: </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">There is no time limit for the other listed presumptive diseases in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2e5c76c208b1756392a6977c7ac7ad92&amp;mc=true&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a>.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Previously, respiratory cancers (cancers of the lung, bronchus, larynx, and trachea) had to become manifest within 30 years of last exposure.  <em>PL 107-103</em> eliminated this requirement effective January 1, 2002.</span></span></div></li><li class=\"BulletText1\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">For the purposes of establishing onset within the required manifestation period, the <b><i>last date of herbicide exposure</i></b> is the last date on which the Veteran served in a location associated with a presumption of herbicide exposure as listed in <a href=\"https://www.law.cornell.edu/uscode/text/38/1116\" target=\"_blank\">38 U.S.C. 1116</a>.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on </span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">time limits for manifestation of diseases subject to presumptive SC, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1307&amp;rgn=div8\" target=\"_blank\">38 CFR 3.307(a)(6)(ii)</a></span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.1.f<a id=\"1f\" name=\"1f\">.</a>  Considering Direct SC When Entitlement to Presumption Does Not Exist</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">If entitlement to presumptive SC based on herbicide exposure does not exist, consider entitlement to SC on a direct, facts-found basis under the toxic exposure risk activity (TERA) procedures.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><em><strong>Notes</strong></em>:</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=153e89209bb95bdd7fc32a497117a512&amp;mc=true&amp;node=se38.1.3_1303&amp;rgn=div8\" target=\"_blank\">38 CFR 3.303(d)</a>, the presumptive provisions of the statute and VA regulations implementing them are intended as liberalizations that allow for another basis of SC.  Therefore, these provisions do <em>not</em> preclude direct SC, where appropriate.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">TERA procedures went into effect on August 10, 2022, under <i>PL 117-168</i>, Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics (PACT) Act of 2022.</span></span></li></ul><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i><span style=\"color: black\">References</span></i></b>:  For more information on </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">TERA procedures, see the <em><a href=\"https://vbaw.vba.va.gov/bl/21/pact.htm\" target=\"_blank\">PACT Act Implementation Standard Operating Procedure (SOP)</a></em>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">conditions determined to have no positive association with herbicide exposure, see <a href=\"#1i\" target=\"_self\">M21-1, Part VIII, Subpart i, 1.B.1.i</a>.</span></span></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.1.g<a id=\"1g\" name=\"1g\">.</a>  Date Disabilities Became Subject to Presumptive SC Under 38 CFR 3.309(e)</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The table below shows the dates on which the diseases listed in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a> became subject to presumptive SC.</span></span></div><div></div><table align=\"center\" border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 488px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a disability-effective date table.  Column 1 contains the disability and column 2 contains the effective date.\"><thead><tr><th scope=\"col\" style=\"width: 263px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Disability</strong></span></span></div></th><th scope=\"col\" style=\"width: 240px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Effective Date</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 263px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Chloracne or other acne-form disease consistent with chloracne, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">soft-tissue sarcoma, <em>other than</em></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">osteosarcoma</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">chondrosarcoma</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Kaposi’s sarcoma, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">mesothelioma</span></span></div></li></ul></li></ul></td><td style=\"width: 240px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">February 6, 1991</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  Originally, September 25, 1985, under 38 CFR 3.311a.</span></span></div></td></tr><tr><td style=\"width: 263px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Non-Hodgkin’s lymphoma (NHL)</span></span></div></td><td style=\"width: 240px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">February 6, 1991</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  Originally, August 5, 1964, under 38 CFR 3.313.</span></span></div></td></tr><tr><td style=\"width: 263px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">PCT, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Hodgkin’s disease</span></span></div></li></ul></td><td style=\"width: 240px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">February 3, 1994</span></span></div></td></tr><tr><td style=\"width: 263px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Respiratory cancers of the</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">lung</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">bronchus</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">larynx, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">trachea, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">multiple myeloma</span></span></div></li></ul></td><td style=\"width: 240px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">June 9, 1994</span></span></div></td></tr><tr><td style=\"width: 263px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Prostate cancer, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">acute and subacute peripheral neuropathy</span></span></div></li></ul></td><td style=\"width: 240px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">November 7, 1996</span></span></div></td></tr><tr><td style=\"width: 263px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Type 2 diabetes mellitus</span></span></div></td><td style=\"width: 240px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">May 8, 2001</span></span></div></td></tr><tr><td style=\"width: 263px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Chronic lymphocytic leukemia (CLL)</span></span></div></td><td style=\"width: 240px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">October 16, 2003</span></span></div></td></tr><tr><td style=\"width: 263px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">AL amyloidosis</span></span></div></td><td style=\"width: 240px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">May 7, 2009</span></span></div></td></tr><tr><td style=\"width: 263px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Ischemic heart disease (IHD)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">chronic B-cell leukemia, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Parkinson’s disease</span></span></div></li></ul></td><td style=\"width: 240px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">August 31, 2010</span></span></div></td></tr><tr><td style=\"width: 263px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Early-onset peripheral neuropathy</span></span></div></td><td style=\"width: 240px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">September 6, 2013</span></span></div></td></tr><tr><td id=\"cke_tmp_585\" style=\"width: 263px; padding: 1px;\"><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Parkinsonism</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">bladder cancer, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">hypothyroidism.</span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Reference</i></b>:  For more information on presumptive SC for these disabilities, see</span></span></div><ul><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><i>PL 116-283</i>, <i>William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021</i>, and</span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://vbaw.vba.va.gov/USB/letters/2021/20-21-07.pdf\" target=\"_blank\"><i>Veterans Benefits Administration (VBA) Letter 20-21-07, Processing Guidance for Claims and Appeals for New Agent Orange Presumptive Conditions</i></a>.</span></span></div></li></ul></td><td style=\"width: 240px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">January 1, 2021</span></span></div></td></tr><tr><td style=\"width: 263px; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">monoclonal gammopathy of undetermined significance, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">hypertension</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><em><strong>Reference</strong></em>:  For more information on processing claims for these disabilities, see the <em><a href=\"https://vbaw.vba.va.gov/bl/21/pact.htm\" target=\"_blank\">PACT Act Implementation SOP</a></em>.</span></span></div></td><td style=\"width: 240px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">August 10, 2022</span></span></div></td></tr></tbody></table><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Important</em></strong>:  The table above includes reference to acute and subacute peripheral neuropathy becoming subject to presumptive SC on November 7, 1996, for historical purposes. The covered disease was revised to early-onset peripheral neuropathy by change effective September 6, 2013.  For claims on or after September 6, 2013, entitlement to presumptive SC based on peripheral neuropathy only exists when the Veteran meets qualifying service requirements specified at <a href=\"#1c\" target=\"_self\">M21-1, Part VIII, Subpart i, 1.B.1.c</a> and medical evidence establishes a confirmed diagnosis of early-onset peripheral neuropathy.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  Unless an earlier effective date is determined pursuant to the <em>Nehmer</em> stipulation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=730552af9f371c1ffbf4acea2daa806b&amp;node=se38.1.3_1816&amp;rgn=div8\" target=\"_blank\">38 CFR 3.816</a>, the provisions pertaining to retroactive payment under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 3.114(a)</a> apply.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on the <em>Nehmer </em>stipulation, see </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1816&amp;rgn=div8\" target=\"_blank\">38 CFR 3.816</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000177426\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 2, Section B - Determining Eligibility to Retroactive Payment Under the Nehmer Stipulation\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177426/M21-1-Part-VIII-Subpart-i-Chapter-2-Section-B-Determining-Eligibility-to-Retroactive-Payment-Under-the-Nehmer-Stipulation\">M21-1, Part VIII, Subpart i, 2.B</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the <a href=\"https://vbaw.vba.va.gov/bl/21/rating/agentorange.htm\" target=\"_blank\"><em>Nehmer Training Guide</em></a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.1.h<a id=\"1h\" name=\"1h\">.</a>  Processing Claims Based on Early-Onset Peripheral Neuropathy</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">A change to <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1307&amp;rgn=div8\" target=\"_blank\">38 CFR 3.307(a)(6)</a> and <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a> (<a href=\"http://www.gpo.gov/fdsys/pkg/FR-2013-09-06/html/2013-21674.htm\" target=\"_blank\">78 FR 54763</a>) effective September 6, 2013, removed requirements that neuropathy must resolve within two years.</span></span></div><div><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></div><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">Do not deny presumptive SC for early-onset peripheral neuropathy solely because the condition persisted for more than two years after initial diagnosis.</span></span></div><div></div><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong><em>Important</em></strong>: </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The regulatory amendment does not change that peripheral neuropathy must manifest to a compensable degree of 10 percent or more within one year of the date of last herbicide exposure during active military, naval, or air service. </span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Claims of SC for later-occurring onset of peripheral neuropathy can only be evaluated under other bases (for example, direct or secondary).  NAS has determined that evidence does not support an association between herbicide exposure and delayed-onset peripheral neuropathy, which NAS defined as having its onset more than one year after exposure.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.1.i<a id=\"1i\" name=\"1i\">.</a>  Conditions Determined to Have No Positive Association With Herbicide Exposure</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">When processing claims for disabilities not recognized as presumptive to herbicide exposure, follow the direct SC TERA procedures.  Review the claimed disability and determine if it falls under the exception for conditions determined to have no positive association with herbicide exposure listed below.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Based on cumulative scientific data reported by NAS since 1993, the Secretary has determined that a positive association does not exist between herbicide exposure and the following conditions and that a presumption of SC is not warranted for any of the conditions:</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Cancers</span></span><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">bone and connective tissue</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">brain and nervous system (including eye)</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">digestive (esophageal, stomach, and colorectal (including small intestine and anus))</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">endocrine (including thyroid and thymus)</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">hepatobiliary (liver, gallbladder, and bile ducts) and pancreatic</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">leukemia (<strong><em>excluding </em></strong>all chronic B-cell leukemias including CLL and hairy cell)</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">nasal cavity (including ears and sinuses)</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">oral cavity (including lips and tongue)</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">pharynx (including tonsils)</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">pleura, mediastinum, and other unspecified sites within the respiratory system and intrathoracic organs</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">skin (including melanoma and nonmelanoma (basal cell and squamous cell), and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">reproductive (including the cervix, uterus, ovary, testes, breast, and penis, but <strong><em>excluding </em></strong>prostate)</span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">.</span></span></li></ul></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Other</span></span><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">asthma</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">chronic obstructive pulmonary disease (COPD)</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">circulatory disorders (<strong><em>but excluding </em></strong>hypertension, IHD, and stroke)</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">endometriosis</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">eye diseases</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Farmer’s lung</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">gastrointestinal, metabolic, and digestive disorders</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">hearing loss</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">immune system disorders (immune suppression, allergy, and autoimmunity)</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">neurobehavioral (cognitive and neuropsychiatric) disorders</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">neurodegenerative diseases (including amyotrophic lateral sclerosis (ALS), but <strong><em>excluding </em></strong>Parkinson's disease and Parkinsonism)</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">osteoporosis, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">chronic peripheral nervous system disorders (<strong><em>but</em></strong> <strong><em>excluding </em></strong>early-onset peripheral neuropathy)</span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">.</span></span></li></ul></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  No positive association means that the evidence for an association does not equal or outweigh the evidence against association.</span></span></div><div></div><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>References</i></b>:  For more information on</span></span></div><ul><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">processing TERA claims, see the <a href=\"https://vbaw.vba.va.gov/bl/21/pact.htm\" target=\"_blank\"><i>PACT Act Implementation SOP</i></a>, and</span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">TERA exceptions, see <span style=\"color: black\"><a href=\"https://vbaw.vba.va.gov/bl/21/pact.htm\"><i>VBA Letter, 20-24-06, Updated Guidance on Processing Claims involving PACT Act</i></a>.</span></span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.1.j<a id=\"1j\" name=\"1j\">.</a>  Metastasis of a Cancer and Presumptive SC Under 38 CFR 3.307(a)</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Do not establish presumptive SC on the basis of herbicide exposure under <a href=\"https://www.law.cornell.edu/uscode/text/38/1116\" target=\"_blank\">38 U.S.C. 1116</a> and <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=7f2b5aa07ce723e019ae7382e4df5dac&amp;mc=true&amp;node=se38.1.3_1307&amp;rgn=div8\" target=\"_blank\">38 CFR 3.307(a)</a> for a cancer listed in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=7f2b5aa07ce723e019ae7382e4df5dac&amp;mc=true&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a> when medical evidence factually shows that the cancer developed as the result of metastasis of a cancer located at a primary site that is not recognized by the VA as associated with herbicide exposure.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  Such evidence constitutes affirmative evidence to rebut the presumption of SC based on herbicide exposure.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.1.k<a id=\"1k\" name=\"1k\">.</a>  Centralized Processing for Rating and Authorization of Herbicide Claims</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Centralized processing of the rating and authorization activities is required for certain herbicide claims.  These include cases with</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">explicit or implicit claims of RVN-based nautical service, and</span></span><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">no in-country service at a presumptive herbicide location, or</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">a previously denied claim based on no qualifying service, or</span></span></li></ul></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">service in the RVN, <i>and</i> potential <i>Nehmer</i> applicability under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=730552af9f371c1ffbf4acea2daa806b&amp;node=se38.1.3_1816&amp;rgn=div8\" target=\"_blank\">38 CFR 3.816</a>. </span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>References</i></b>:  For more information on</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">explicit or implicit claims of RVN-based nautical service, see the <a href=\"https://vbaw.vba.va.gov/bl/21/pact.htm\" target=\"_blank\"><i>PACT Act Implementation SOP</i></a> content titled, <i>Evidence of Nautical Service</i>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">claims requiring centralized processing for research of herbicide exposure, see <a articleid=\"554400000177422\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 1, Section A - Developing Claims for Service Connection (SC) Based on Herbicide Exposure\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177422/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-A-Developing-Claims-for-Service-Connection-SC-Based-on-Herbicide-Exposure\">M21-1, Part VIII, Subpart i, 1.A.1.c</a></span></span><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"color: black\">.</span> </span></span></li></ul></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><h2 class=\"ng-scope\"></h2><h2 class=\"ng-scope\"><br/><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">2.<a id=\"2\" name=\"2\"></a> Considering SC for Disabilities Associated With Service in the RVN</span></span></h2><p class=\"ng-scope\"></p><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This topic contains information on SC for disabilities associated with service in the RVN, including</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#2a\" target=\"_self\">SC for NHL under 38 CFR 3.313 based on service in the RVN during the Vietnam era</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#2b\" target=\"_self\">subcategories of NHL qualifying for presumptive SC</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><strong><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></strong></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">December 4, 2023</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.2.a<a id=\"2a\" name=\"2a\">.</a>  SC for NHL Under 38 CFR 3.313 Based on Service in the RVN During the Vietnam Era</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">VA regulations at <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1313&amp;rgn=div8\" target=\"_blank\">38 CFR 3.313</a> provide for a presumption of SC for NHL based on service in the RVN during the Vietnam era.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Important</em></strong>:  </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Exposure to herbicides is not a prerequisite for entitlement under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1313&amp;rgn=div8\" target=\"_blank\">38 CFR 3.313</a>.  The claimant needs only to show service in the RVN, which includes the waters offshore.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">If a claim for NHL under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1313&amp;rgn=div8\" target=\"_blank\">38 CFR 3.313</a> requires research of RVN nautical service, it must be referred for centralized processing as noted in <a articleid=\"554400000177422\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 1, Section A - Developing Claims for Service Connection (SC) Based on Herbicide Exposure\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177422/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-A-Developing-Claims-for-Service-Connection-SC-Based-on-Herbicide-Exposure\">M21-1, VIII, Subpart i, 1.A.1.c</a>.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><em><strong>Reference</strong></em>:  For more information on presumptive SC for NHL based on presumptive herbicide exposure, see</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=7f2b5aa07ce723e019ae7382e4df5dac&amp;mc=true&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#1g\" target=\"_self\">M21-1, Part VIII, Subpart i, 1.B.1.g</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.2.b<a id=\"2b\" name=\"2b\">.</a>  Subcategories of NHL Qualifying for Presumptive SC</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">When <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1313&amp;rgn=div8\" target=\"_blank\">38 CFR 3.313</a> was promulgated, the U.S. Center for Disease Control identified a number of subcategories that are manifestations of NHL.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Extend the presumption of SC to a Veteran who claims SC for NHL if</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the Veteran had service in the RVN during the Vietnam era, including naval service in the offshore waters of the RVN, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the medical evidence shows a diagnosis of any of the subcategories of low, intermediate, or high-grade lymphoma listed in the table below.</span></span></div></li></ul><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" spellcheck=\"false\" style=\"width: 500px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a low grade-intermediate grade-high grade lymphoma table.  Column 1 contains low grade lymphomas, column 2 contains intermediate grade lymphomas and column 3 contains high grade lymphomas.\"><thead><tr><th scope=\"col\" style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Low Grade Lymphoma</strong></span></span></div></th><th scope=\"col\" style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Intermediate Grade Lymphoma</strong></span></span></div></th><th scope=\"col\" style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>High Grade Lymphoma</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Small lymphocytic with plasmacytoid features</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Diffuse, small and large</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Diffuse, small and large</span></span></div></td></tr><tr><td style=\"height: 19px; width: 168px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Small lymphocytic lymphoma and B-cell CLL</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  Small lymphocytic lymphoma and B-cell CLL are considered slightly different forms of the same disease.</span></span></div></td><td style=\"height: 19px; width: 168px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Diffuse, small cleaved</span></span></div></td><td style=\"height: 19px; width: 168px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Lymphoblastic</span></span></div></td></tr><tr><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Intermediate cell</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Diffuse, large cleaved</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Immunoblastic</span></span></div></td></tr><tr><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Follicular, mixed small and large</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Diffuse, large non-cleaved</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Burkitt’s</span></span></div></td></tr><tr><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Mantle zone</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Diffuse, large</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">---</span></span></div></td></tr><tr><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Follicular, small cleaved</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Follicular, large</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">---</span></span></div></td></tr><tr><td style=\"height: 19px; width: 168px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Waldenstrom’s macroglobulinemia</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">---</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">---</span></span></div></td></tr><tr><td style=\"height: 19px; width: 168px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Mycosis fungoides</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on considering claims for SC for mycosis fungoides, see <a articleid=\"554400000180515\" articlename=\"M21-1, Part V, Subpart iii, Chapter 10 - Skin Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180515/M21-1-Part-V-Subpart-iii-Chapter-10-Skin-Conditions\">M21-1, Part V, Subpart iii, 10.4.c</a>.</span></span></div></td><td style=\"height: 19px; width: 168px; vertical-align: middle; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">---</span></span></div></td><td style=\"height: 19px; width: 168px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">---</span></span></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"> <span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">3.<a id=\"3\" name=\"3\"></a> Impact of Historical Herbicide Exposure Policies</span></span></h2><p class=\"ng-scope\"></p><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This topic contains information on the impact of historical herbicide exposure policies, including</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#3a\" target=\"_self\">overview of historical policies regarding herbicide exposure and nautical service</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#3b\" target=\"_self\">benefits previously awarded under historical policies</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><strong><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></strong></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">December 4, 2023</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.3.a<a id=\"3a\" name=\"3a\">.</a>  Overview of Historical Policies Regarding Herbicide Exposure and Nautical Service</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The table below represents time periods during which VA had specific policies in place regarding concession of herbicide exposure based on nautical service.</span></span></div><div></div><div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a two column table.  Column 1 contains the guidance time period and column 2 contains the exposure policy during that time.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 184px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Guidance Time Period</strong></span></span></div></th><th scope=\"col\" style=\"width: 326px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Exposure Policy</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 184px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">pre-<em>Haas</em> (1991-2002)</span></span></div></td><td style=\"width: 326px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Exposure conceded based on receipt of the Vietnam Service Medal (VSM).</span></span></div></td></tr><tr><td style=\"width: 184px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">2002</span></span></div></td><td style=\"width: 326px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Removed concession for VSM from M21-1 guidance.</span></span></div></td></tr><tr><td style=\"width: 184px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Fast Letter (FL) 06-26</em> (December 11, 2006)</span></span></div></td><td style=\"width: 326px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">All blue water Navy claims stayed based on the <em>Haas</em> decision.</span></span></div></td></tr><tr><td style=\"width: 184px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Haas</em> stay lifted, <em>FL 09-07</em> (February 6, 2009)</span></span></div></td><td style=\"width: 326px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Exposure conceded based on review of military records for</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">inland waterways service of the RVN, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">service on a ship that docked, if the Veteran provided a lay statement that he went ashore. </span></span></div></li></ul></td></tr><tr><td style=\"width: 184px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Training Letter 10-06</em> (September 9, 2010)</span></span></div></td><td style=\"width: 326px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Concession based on categories of ships on the <em>Navy and Coast Guard Ships Associated with Service in Vietnam and Exposure to Herbicide Agents</em>, a.k.a., the Ships List.</span></span></div></td></tr><tr><td style=\"width: 184px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Veterans Service Center Manager (VSCM) Call (January 2011)</span></span></div></td><td style=\"width: 326px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Ships List updated with Category IV, <em>Ships operating on Vietnam’s close coastal waters for extended periods with evidence that crew members went ashore</em> (lay statement of going ashore required).</span></span></div></td></tr><tr><td style=\"width: 184px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">VSCM Call (May 2011)</span></span></div></td><td style=\"width: 326px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Ships List updated with Category V, <em>Ships operating on Vietnam’s close coastal waters for extended periods with evidence that smaller craft from the ship regularly delivered supplies or troops ashore</em> (lay statement of going ashore required).</span></span></div></td></tr><tr><td style=\"width: 184px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>PL 116-23</em> (January 1, 2020)</span></span></div></td><td style=\"width: 326px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Definition of service in the RVN expanded to include eligible offshore waters.  Use of the Ships List discontinued and replaced with VBA’s internal claims processing tools used to determine a ship’s location(s).</span></span></div></td></tr><tr><td style=\"width: 184px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">PACT Act (August 10, 2022)</span></span></div></td><td style=\"width: 326px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Expanded presumptive herbicide exposure to additional nautical locations by amending <a href=\"https://www.law.cornell.edu/uscode/text/38/1116\" target=\"_blank\">38 U.S.C. 1116</a>.</span></span></div></td></tr></tbody></table><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.3.b<a id=\"3b\" name=\"3b\">.</a>  Benefits Previously Awarded Under Historical Policies</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When reviewing initial or supplemental claims decided under historical nautical service herbicide exposure policies, <strong><em>do not</em></strong></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">propose to sever SC for the disabilities previously awarded when the presumption of herbicide exposure was conceded under former policies, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">concede herbicide exposure for any newly claimed disabilities unless evidence is presented that otherwise establishes the Veteran’s exposure based on current evidentiary requirements.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>: </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Before deciding any initial or supplemental claim based on herbicide exposure, always apply the most current standards and definitions of qualifying service and review all available records.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The protection noted above applies to SC for the disability awarded based on a historical policy.  Once a disability has been service-connected (SC), even erroneously, and protection has attached, then the Veteran is entitled to increased evaluations for the disability, to SC for secondary conditions, and to awards of individual unemployability based solely or partly on those SC conditions.</span></span></div></li></ul></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">protection of SC, see </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=f1698be6d3e3a873bef5218962c9756f&amp;mc=true&amp;node=se38.1.3_1957&amp;rgn=div8\" target=\"_blank\">38 CFR 3.957</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.law.cornell.edu/uscode/text/38/1159\" target=\"_blank\">38 U.S.C. 1159</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">new interpretations of the law and clear and unmistakable error, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000135678\" articlename=\"Berger v. Brown, Mar 21, 1997, 10 Vet.App. 166 (1997)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000135678/Berger-v-Brown-Mar-21-1997-10-VetApp-166-1997\"><em>Berger v. Brown</em></a>, 10 Vet. App. 166 (1997), and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000015165\" articlename=\"Jordan v. Nicholson, Mar 15, 2005, 401 F.3d 1296\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000015165/Jordan-v-Nicholson-Mar-15-2005-401-F3d-1296\"><em>Jordan v. Nicholson</em></a>, 401 F.3d 1296 (Fed. Cir. 2005), and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">blue water Navy Veterans and herbicide exposure, see <a articleid=\"554400000014856\" articlename=\"Haas v. Peake, May 8, 2008, 525 F.3d 1168\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014856/Haas-v-Peake-May-8-2008-525-F3d-1168\"><em>Haas v. Peake</em></a>, 535 F.3d 1168 (Fed. Cir. 2008).</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><h2 class=\"ng-scope\"></h2><h2 class=\"ng-scope\"><br/><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">4.<a id=\"4\" name=\"4\"></a> Effective Date Determinations in Herbicide Exposure Claims</span></span></h2><p class=\"ng-scope\"></p><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This topic contains information on effective date determinations in herbicide exposure claims, including</span></span></div><ul><li><div><a href=\"#4a\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">maximizing benefits with effective date determinations in herbicide claims</span></span></a></div></li><li><div><a href=\"#4b\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">effective dates based on herbicide exposure and CFR 3.156(c)</span></span></a></div></li><li><div><a href=\"#4c\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">determining applicability of 38 CFR 3.156(c) or 38 CFR 3.114 for exposure to herbicides in Korea</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">, and</span></span></div></li><li><div><a href=\"#4d\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">examples of determining effective date in a claim based on herbicide exposure in Korea</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><strong><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></strong></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">July 29, 2021</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">VIII.i.1.B.4.a<a id=\"4a\" name=\"4a\">.</a>  Maximizing Benefits With Effective Date Determinations in Herbicide Claims</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When awarding SC for a disability under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=7f2b5aa07ce723e019ae7382e4df5dac&amp;mc=true&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a>, different provisions allow for assignment of an effective date.  In such cases, consider each effective date rule and assign the most advantageous effective date that applies for the facts of the case.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Use the table below to determine which effective date rule may apply to an award of SC for a <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=7f2b5aa07ce723e019ae7382e4df5dac&amp;mc=true&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a> disability.</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 624px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an if-then-reference table.  Column 1 contians the criteria, column 2 contains the regulation to consider an effective date under and column 3 contains additional references.\" width=\"624\"><thead><tr><th scope=\"col\" style=\"width: 276px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>If ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 204px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Then consider entitlement to an effective date under ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 144px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Reference</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 276px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the claimant filed the claim prior to the date VA added the presumptive disability to <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=7f2b5aa07ce723e019ae7382e4df5dac&amp;mc=true&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a></span></span></div></td><td style=\"width: 204px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1816&amp;rgn=div8\" target=\"_blank\">38 CFR 3.816</a>.</span></span></div></td><td style=\"width: 144px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000177426\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 2, Section B - Determining Eligibility to Retroactive Payment Under the Nehmer Stipulation\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177426/M21-1-Part-VIII-Subpart-i-Chapter-2-Section-B-Determining-Eligibility-to-Retroactive-Payment-Under-the-Nehmer-Stipulation\">M21-1, Part VIII, Subpart i, 2.B</a></span></span></div></td></tr><tr><td style=\"width: 276px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the claimant met all eligibility criteria for a benefit on the effective date of a liberalizing law change as detailed in <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">M21-1, Part V, Subpart ii, 4.A.6.h</a></span></span></div></td><td style=\"width: 204px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=947dea7679e9781ad78ce64e50959e4e&amp;mc=true&amp;node=se38.1.3_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 3.114(a)</a>.</span></span></div></td><td style=\"width: 144px; vertical-align: top; padding: 1px;\"><div><a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">M21-1, Part V, Subpart ii, 4.A.6</span></span></a></div></td></tr><tr><td style=\"width: 276px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the claimant is entitled to retroactive payment of benefits based on <em>PL 116-23</em></span></span></div></td><td style=\"width: 204px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.law.cornell.edu/uscode/text/38/1116A\" target=\"_blank\">38 U.S.C. 1116A</a>.</span></span></div></td><td style=\"width: 144px; padding: 1px;\"><div><em><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"https://dvagov.sharepoint.com/sites/VBA21CBWN/INQ/Shared Documents/Forms/AllItems.aspx?viewpath=%2Fsites%2FVBA21CBWN%2FINQ%2FShared%20Documents%2FForms%2FAllItems%2Easpx&amp;id=%2Fsites%2FVBA21CBWN%2FINQ%2FShared%20Documents%2FSOPs&amp;viewid=1d3cdf97%2D0fa6%2D452c%2Dbcbb%2D617998b4cb3b\" target=\"_blank\">Nautical Herbicide Exposure Centralized Processing SOP</a></span></span></em></div></td></tr><tr><td style=\"width: 276px; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the claim was previously denied because available service records did not establish the Veteran had qualifying service, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">newly received service records establish service in a qualifying location</span></span></div></li></ul></td><td style=\"width: 204px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=95b634fd8c286ed358f7ffac4fbec003&amp;node=se38.1.3_1156&amp;rgn=div8\" target=\"_blank\">38 CFR 3.156(c)</a>.</span></span></div></td><td style=\"width: 144px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4b\" target=\"_self\">M21-1, Part VIII, Subpart i, 1.B.4.b</a>-<a href=\"#4d\" target=\"_self\">d</a></span></span></div></td></tr><tr><td style=\"width: 276px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">none of the above special provisions apply</span></span></div></td><td style=\"width: 204px; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=28f7dc456a02310276f9dc318b73d844&amp;mc=true&amp;node=se38.1.3_1400&amp;rgn=div8\" target=\"_blank\">38 CFR 3.400</a>, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=c08a3c62e4c2007c26da4379059b6e93&amp;mc=true&amp;node=se38.1.3_12500&amp;rgn=div8\" target=\"_blank\">38 CFR 3.2500</a>.</span></span></div></li></ul></td><td style=\"width: 144px; vertical-align: top; padding: 1px;\"><div><a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">M21-1, Part V, Subpart ii, 4.A</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">.</span></span></div></td></tr></tbody></table><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><em><strong>Reference</strong></em>:  For more information on establishing an effective date under the PACT Act, see the <em><a href=\"https://vbaw.vba.va.gov/bl/21/pact.htm\" target=\"_blank\">PACT Act Implementation SOP</a></em>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">VIII.i.1.B.4.b<a id=\"4b\" name=\"4b\">.</a>  Effective Dates Based on Herbicide Exposure and CFR 3.156(c)</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If a claim based on exposure to herbicides was previously denied because available service records did not establish the Veteran had qualifying service, decision makers must review any newly available service records to determine if new evidence of qualifying service exists.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Reconsider the claim under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=08b0195c7b398df97c1eb4e1a92a964f&amp;mc=true&amp;node=se38.1.3_1156&amp;rgn=div8\" target=\"_blank\">38 CFR 3.156(c)</a> if newly received service records result in</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">presumption of herbicide exposure based on location of service, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">concession of herbicide exposure on a factual basis.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">As stated in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=08b0195c7b398df97c1eb4e1a92a964f&amp;mc=true&amp;node=se38.1.3_1156&amp;rgn=div8\" target=\"_blank\">38 CFR 3.156(c)(3)</a>, if the evidence now justifies the establishment of SC, the effective date will be the later of </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the date entitlement arose, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the date VA received the previously decided claim.</span></span></div></li></ul><div style=\"margin-left: -1.45pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The date entitlement arose may be either the</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">date the claimed disease was diagnosed (or symptoms became manifest according to medical evidence), or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the date the claimed presumptive disease was finalized as part of the presumptive list of herbicide exposure-related diseases in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=08b0195c7b398df97c1eb4e1a92a964f&amp;mc=true&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(e)</a>.</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Decision makers must also consider the effective date provisions of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c847914fbf038e2920ae9f5b3b98e266&amp;mc=true&amp;node=se38.1.3_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 3.114</a> and the <em>Nehmer</em> stipulation, when applicable.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">developing claims based on herbicide exposure, see <a articleid=\"554400000177422\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 1, Section A - Developing Claims for Service Connection (SC) Based on Herbicide Exposure\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177422/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-A-Developing-Claims-for-Service-Connection-SC-Based-on-Herbicide-Exposure\">M21-1, Part VIII, Subpart i, 1.A</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the <em>Nehmer</em> stipulation, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&amp;node=se38.1.3_1816&amp;rgn=div8\" target=\"_blank\">38 CFR 3.816</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000177426\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 2, Section B - Determining Eligibility to Retroactive Payment Under the Nehmer Stipulation\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177426/M21-1-Part-VIII-Subpart-i-Chapter-2-Section-B-Determining-Eligibility-to-Retroactive-Payment-Under-the-Nehmer-Stipulation\">M21-1, Part VIII, Subpart i, 2.B</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the <a href=\"https://vbaw.vba.va.gov/bl/21/rating/agentorange.htm\" target=\"_blank\"><em>Nehmer Training Guide</em></a>.</span></span></div></li></ul></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">VIII.i.1.B.4.c<a id=\"4c\" name=\"4c\">.</a>  Determining Applicability of 38 CFR 3.156(c) or 38 CFR 3.114 for Exposure to Herbicides in Korea </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Effective dates based on a grant of SC for a disability associated with exposure to herbicides in the Korean DMZ can be affected by liberalizing changes and/or receipt of additional service department records. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Two</em> liberalizing changes to the provisions of <a href=\"https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=cbdeae7f07f67d7744142e74da4bad47&amp;mc=true&amp;r=SECTION&amp;n=se38.1.3_1307\" target=\"_blank\">38 CFR 3.307(a)(6)(iv)</a> (as discussed more thoroughly in <a articleid=\"554400000177422\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 1, Section A - Developing Claims for Service Connection (SC) Based on Herbicide Exposure\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177422/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-A-Developing-Claims-for-Service-Connection-SC-Based-on-Herbicide-Exposure\">M21-1, Part VIII, Subpart i, 1.A.3.b</a>) have been made to revise the applicable dates for the concession of exposure to herbicides for Veterans who served in specific designated units operating in or near the Korean DMZ. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When a claim for SC associated with exposure to herbicides in Korea was previously denied, but entitlement to the benefit is now established based on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">expanded regulatory authority not in effect at the time of the prior decision, apply <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=6b4ec8e1cf50d3127427a819f4b1a29b&amp;mc=true&amp;node=se38.1.3_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 3.114(a)</a> if all other criteria for applicability are satisfied, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">new service records received from the service department that establish exposure based on the regulatory provision in place at the time of the previously adjudicated claim, apply <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=600978a819a94da61559e6ff40261fa6&amp;mc=true&amp;node=se38.1.3_1156&amp;rgn=div8\" target=\"_blank\">38 CFR 3.156(c)</a> if all other criteria for applicability are satisfied.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">considering additional service records, see <a articleid=\"554400000177964\" articlename=\"M21-1, Part X, Subpart ii, Chapter 2, Section B - Revision Based on Receipt of Supplemental Service Records\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177964/M21-1-Part-X-Subpart-ii-Chapter-2-Section-B-Revision-Based-on-Receipt-of-Supplemental-Service-Records\">M21-1, Part X, Subpart ii, 2.B</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assigning effective dates based on liberalizing regulatory changes, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=6b4ec8e1cf50d3127427a819f4b1a29b&amp;mc=true&amp;node=se38.1.3_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 3.114(a)</a>, and </span></span></div></li><li><div><a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">M21-1, Part V, Subpart ii, 4.A.6</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">requirements for presumptive SC based on herbicide exposure in the Korean DMZ, see <a articleid=\"554400000177422\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 1, Section A - Developing Claims for Service Connection (SC) Based on Herbicide Exposure\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177422/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-A-Developing-Claims-for-Service-Connection-SC-Based-on-Herbicide-Exposure\">M21-1, Part VIII, Subpart i, 1.A.3.a</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">VIII.i.1.B.4.d<a id=\"4d\" name=\"4d\">.</a>  Examples of Determining Effective Date in a Claim Based on Herbicide Exposure in Korea </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Facts</em></strong>:  The Veteran previously claimed and was denied SC for prostate cancer due to herbicide exposure in Korea.  The Veteran was notified of the denial on July 18, 2010.  The service records at that time showed that the Veteran served in a designated unit in the Korean DMZ, but the dates of service were in October to November 1970.  The Veteran has submitted a supplemental claim for SC for prostate cancer due to herbicide exposure in Korea. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Analysis</em></strong>:  The liberalizing law change of February 24, 2011, expanded the applicable dates for presumption of exposure for Veterans who served in a designated unit in the Korean DMZ to include dates of service through August 31, 1971.  Since the Veteran’s service in 1970 falls within the designated time period, SC is now warranted.  Given that SC is warranted based on the liberalizing law change expanding the applicable time period associated with Korean service, apply <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=6b4ec8e1cf50d3127427a819f4b1a29b&amp;mc=true&amp;node=se38.1.3_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 3.114</a> to assign an effective date one year prior to the date of receipt of the supplemental claim if all other criteria for applicability of this regulation are otherwise satisfied.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Facts</em></strong>:  The Veteran previously claimed and was denied SC for lung cancer due to herbicide exposure in Korea.  The claim was received on March 12, 2015, and the Veteran was notified of the denial on August 22, 2015.  The Veteran claimed to have been assigned on temporary duty orders to a designated unit in the DMZ during the spring of 1969.  Development attempts were made for records of the Veteran’s assignments, and no evidence was received to verify the claimed service.  In 2019, the Veteran submitted a supplemental claim with new and relevant evidence.  Development for that claim revealed recently declassified records confirming that the Veteran was sent on temporary duty orders to a designated unit in the Korean DMZ in 1969. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Analysis</em></strong>:  Receipt of additional service records confirming service in a designated unit in the Korean DMZ in 1969 is sufficient to allow presumption of herbicide exposure under <a href=\"https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=cbdeae7f07f67d7744142e74da4bad47&amp;mc=true&amp;r=SECTION&amp;n=se38.1.3_1307\" target=\"_blank\">38 CFR 3.307(a)(6)(iv)</a>.  Assuming all other criteria are met, the prior denial of SC must be reconsidered and revised under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=600978a819a94da61559e6ff40261fa6&amp;mc=true&amp;node=se38.1.3_1156&amp;rgn=div8\" target=\"_blank\">38 CFR 3.156(c)</a>.  SC for lung cancer is warranted effective March 12, 2015.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000177422\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 1, Section A - Developing Claims for Service Connection (SC) Based on Herbicide Exposure\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177422/M21-1-Part-VIII-Subpart-i-Chapter-1-Section-A-Developing-Claims-for-Service-Connection-SC-Based-on-Herbicide-Exposure\">&lt;-- Previous Section</a>  <a articleid=\"554400000177424\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 2, Section A - Developing Claims Under the Nehmer Stipulation\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177424/M21-1-Part-VIII-Subpart-i-Chapter-2-Section-A-Developing-Claims-Under-the-Nehmer-Stipulation\">Next Section --&gt;</a></span></span></p><p class=\"ng-scope\" style=\"text-align: left\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 11px\"><a href=\"#top\" target=\"_self\">To Top</a></span></span></p><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&node=se38.1.3_1114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&node=se38.1.3_1307&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&node=se38.1.3_1309&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&node=se38.1.3_1313&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=055c1bf4970910e4b257cfd824ce0b59&node=se38.1.3_1816&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=08b0195c7b398df97c1eb4e1a92a964f&mc=true&node=se38.1.3_1156&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=08b0195c7b398df97c1eb4e1a92a964f&mc=true&node=se38.1.3_1309&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=153e89209bb95bdd7fc32a497117a512&mc=true&node=se38.1.3_1303&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=2e5c76c208b1756392a6977c7ac7ad92&mc=true&node=se38.1.3_1309&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=730552af9f371c1ffbf4acea2daa806b&node=se38.1.3_1816&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=7f2b5aa07ce723e019ae7382e4df5dac&mc=true&node=se38.1.3_1307&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=7f2b5aa07ce723e019ae7382e4df5dac&mc=true&node=se38.1.3_1309&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=947dea7679e9781ad78ce64e50959e4e&mc=true&node=se38.1.3_1114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=95b634fd8c286ed358f7ffac4fbec003&node=se38.1.3_1156&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=c847914fbf038e2920ae9f5b3b98e266&mc=true&node=se38.1.3_1114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=f1698be6d3e3a873bef5218962c9756f&mc=true&node=se38.1.3_1957&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=f97bef91876080300247e2290a6ca2b2&mc=true&node=se38.1.3_1309&rgn=div8",
    "http://www.gpo.gov/fdsys/pkg/FR-2013-09-06/html/2013-21674.htm",
    "https://dvagov.sharepoint.com/sites/VBA21CBWN/INQ/Shared Documents/Forms/AllItems.aspx?viewpath=%2Fsites%2FVBA21CBWN%2FINQ%2FShared%20Documents%2FForms%2FAllItems%2Easpx&id=%2Fsites%2FVBA21CBWN%2FINQ%2FShared%20Documents%2FSOPs&viewid=1d3cdf97%2D0fa6%2D452c%2Dbcbb%2D617998b4cb3b",
    "https://vbaw.vba.va.gov/USB/letters/2021/20-21-07.pdf",
    "https://vbaw.vba.va.gov/bl/21/pact.htm",
    "https://vbaw.vba.va.gov/bl/21/rating/agentorange.htm",
    "https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=cbdeae7f07f67d7744142e74da4bad47&mc=true&r=SECTION&n=se38.1.3_1307",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=28f7dc456a02310276f9dc318b73d844&mc=true&node=se38.1.3_1400&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=600978a819a94da61559e6ff40261fa6&mc=true&node=se38.1.3_1156&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=6b4ec8e1cf50d3127427a819f4b1a29b&mc=true&node=se38.1.3_1114&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=c08a3c62e4c2007c26da4379059b6e93&mc=true&node=se38.1.3_12500&rgn=div8",
    "https://www.law.cornell.edu/uscode/text/38/1116",
    "https://www.law.cornell.edu/uscode/text/38/1116A",
    "https://www.law.cornell.edu/uscode/text/38/1159"
  ],
  "scraped_at": "2025-06-16T22:55:03.922665",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177424/M21-1-Part-VIII-Subpart-i-Chapter-2-Section-A-Developing-Claims-Under-the-Nehmer-Stipulation"
}